Pier Capital, LLC Roivant Sciences Ltd. Transaction History
Pier Capital, LLC
- $714 Million
- Q1 2024
A detailed history of Pier Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Pier Capital, LLC holds 328,182 shares of ROIV stock, worth $3.55 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
328,182
Previous 331,267
0.93%
Holding current value
$3.55 Million
Previous $3.72 Million
7.02%
% of portfolio
0.48%
Previous 0.54%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
265Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$791 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$751 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$723 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$392 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$386 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.63B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...